Updated Characterization of Poliovirus Transmission in Pakistan and Afghanistan and the Impacts of Different Outbreak Response Vaccine Options
- PMID: 33885734
- PMCID: PMC8083227
- DOI: 10.1093/infdis/jiab160
Updated Characterization of Poliovirus Transmission in Pakistan and Afghanistan and the Impacts of Different Outbreak Response Vaccine Options
Abstract
Background: Pakistan and Afghanistan remain the only reservoirs of wild poliovirus transmission. Prior modeling suggested that before the coronavirus disease 2019 (COVID-19) pandemic, plans to stop the transmission of serotype 1 wild poliovirus (WPV1) and persistent serotype 2 circulating vaccine-derived poliovirus (cVDPV2) did not appear on track to succeed.
Methods: We updated an existing poliovirus transmission and Sabin-strain oral poliovirus vaccine (OPV) evolution model for Pakistan and Afghanistan to characterize the impacts of immunization disruptions and restrictions on human interactions (ie, population mixing) due to the COVID-19 pandemic. We also consider different options for responding to outbreaks and for preventive supplementary immunization activities (SIAs).
Results: The modeling suggests that with some resumption of activities in the fall of 2020 to respond to cVDPV2 outbreaks and full resumption on 1 January 2021 of all polio immunization activities to pre-COVID-19 levels, Pakistan and Afghanistan would remain off-track for stopping all transmission through 2023 without improvements in quality.
Conclusions: Using trivalent OPV (tOPV) for SIAs instead of serotype 2 monovalent OPV offers substantial benefits for ending the transmission of both WPV1 and cVDPV2, because tOPV increases population immunity for both serotypes 1 and 2 while requiring fewer SIA rounds, when effectively delivered in transmission areas.
Keywords: dynamic modeling; eradication; outbreak response; polio.
Published by Oxford University Press for the Infectious Diseases Society of America 2021.
Similar articles
-
Insights From Modeling Preventive Supplemental Immunization Activities as a Strategy to Eliminate Wild Poliovirus Transmission in Pakistan and Afghanistan.Risk Anal. 2021 Feb;41(2):266-272. doi: 10.1111/risa.13471. Epub 2020 Mar 6. Risk Anal. 2021. PMID: 32144841 Free PMC article.
-
Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic.Vaccine. 2023 Apr 6;41 Suppl 1:A93-A104. doi: 10.1016/j.vaccine.2021.09.037. Epub 2021 Sep 25. Vaccine. 2023. PMID: 34629206 Free PMC article.
-
Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.BMC Infect Dis. 2016 Jun 1;16:237. doi: 10.1186/s12879-016-1537-8. BMC Infect Dis. 2016. PMID: 27246198 Free PMC article.
-
The immediate impact of the COVID-19 pandemic on polio immunization and surveillance activities.Vaccine. 2023 Apr 6;41 Suppl 1:A2-A11. doi: 10.1016/j.vaccine.2021.10.028. Epub 2021 Oct 22. Vaccine. 2023. PMID: 34756614 Free PMC article. Review.
-
Impact of COVID-19 on polio vaccination in Pakistan: a concise overview.Rev Med Virol. 2021 Jul;31(4):e2190. doi: 10.1002/rmv.2190. Epub 2020 Nov 11. Rev Med Virol. 2021. PMID: 33176028 Review.
Cited by
-
Monitoring the VDPV2 outbreak in Egypt during 2020-2021 highlights the crucial role of environmental surveillance and boosting immunization in combating Poliovirus.BMC Infect Dis. 2024 Aug 26;24(1):866. doi: 10.1186/s12879-024-09731-0. BMC Infect Dis. 2024. PMID: 39187787 Free PMC article.
-
Review of Poliovirus Transmission and Economic Modeling to Support Global Polio Eradication: 2020-2024.Pathogens. 2024 May 22;13(6):435. doi: 10.3390/pathogens13060435. Pathogens. 2024. PMID: 38921733 Free PMC article. Review.
-
Modeling the spread of circulating vaccine-derived poliovirus type 2 outbreaks and interventions: A case study of Nigeria.Vaccine X. 2024 Mar 16;18:100476. doi: 10.1016/j.jvacx.2024.100476. eCollection 2024 Jun. Vaccine X. 2024. PMID: 38617838 Free PMC article.
-
Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences.Risk Anal. 2024 Feb;44(2):366-378. doi: 10.1111/risa.14158. Epub 2023 Jun 21. Risk Anal. 2024. PMID: 37344934 Free PMC article. Review.
-
Outbreak response strategies with type 2-containing oral poliovirus vaccines.Vaccine. 2023 Apr 6;41 Suppl 1(Suppl 1):A142-A152. doi: 10.1016/j.vaccine.2022.10.060. Epub 2022 Nov 17. Vaccine. 2023. PMID: 36402659 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical